Mark A. Dickson MD

Mark A. Dickson, MD as a medical oncologist who specializes in the treatment of sarcomas of soft tissue and bone, Kaposi’s sarcoma, and melanoma. My research is focused on the development of new drugs, including targeted small molecules and antibodies, to treat these diseases. In particular, I study new drugs that block pathways and proteins critical for cancer growth such as the cell cycle pathway in liposarcoma, the Aurora kinase proteins in soft tissue sarcoma, and the Notch pathway in melanoma. My research includes work in HIV-associated Kaposi’s sarcoma in concert with the AIDS Malignancy Consortium. My goal is to find newer, more-effective, and less-toxic therapies to improve the lives of people living with cancer.